Serveur d'exploration Stress et Covid - Analysis (2020)

Index « AbsEn.i » - entrée « therapy »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
therapists < therapy < there  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 31.
[0-20] [0 - 20][0 - 31][20-30][20-40]
Ident.Authors (with country if any)Title
000008 (2020) George Zaki Ghali [États-Unis] ; Michael George Zaki Ghali [États-Unis, Suède]β adrenergic receptor modulated signaling in glioma models: promoting β adrenergic receptor-β arrestin scaffold-mediated activation of extracellular-regulated kinase 1/2 may prove to be a panacea in the treatment of intracranial and spinal malignancy and extra-neuraxial carcinoma
000014 (2020) Kaijin Xu [République populaire de Chine] ; Hongliu Cai [République populaire de Chine] ; Yihong Shen [République populaire de Chine] ; Qin Ni [République populaire de Chine] ; Yu Chen [République populaire de Chine] ; Shaohua Hu [République populaire de Chine] ; Jianping Li [République populaire de Chine] ; Huafen Wang [République populaire de Chine] ; Liang Yu [République populaire de Chine] ; He Huang [République populaire de Chine] ; Yunqing Qiu [République populaire de Chine] ; Guoqing Wei [République populaire de Chine] ; Qiang Fang [République populaire de Chine] ; Jianying Zhou [République populaire de Chine] ; Jifang Sheng [République populaire de Chine] ; Tingbo Liang [République populaire de Chine] ; Lanjuan Li [République populaire de Chine][Management of corona virus disease-19 (COVID-19): the Zhejiang experience].
000040 (2020) Y-X Wang [République populaire de Chine] ; J-R Ma ; S-Q Wang ; Y-Q Zeng ; C-Y Zhou ; Y-H Ru ; L. Zhang ; Z-G Lu ; M-H Wu ; H. LiUtilizing integrating network pharmacological approaches to investigate the potential mechanism of Ma Xing Shi Gan Decoction in treating COVID-19.
000044 (2020) Walter Gottlieb Land [France, Allemagne]Use of DAMPs and SAMPs as Therapeutic Targets or Therapeutics: A Note of Caution
000059 (2020) Ernest H. Choy [Royaume-Uni] ; Fabrizio De Benedetti [Italie] ; Tsutomu Takeuchi [Japon] ; Misato Hashizume [Japon] ; Markus R. John [Suisse] ; Tadamitsu Kishimoto [Japon]Translating IL-6 biology into effective treatments
000066 (2020) Marilù Bartiromo [Italie] ; Beatrice Borchi [Italie] ; Annarita Botta [Italie] ; Alfredo Bagalà [Italie] ; Gianmarco Lugli [Italie] ; Marta Tilli [Italie] ; Annalisa Cavallo [Italie] ; Brunilda Xhaferi [Italie] ; Roberta Cutruzzulà [Italie] ; Augusto Vaglio [Italie] ; Silvia Bresci [Italie] ; Aida Larti [Italie] ; Alessandro Bartoloni [Italie] ; Calogero Cirami [Italie]Threatening drug-drug interaction in a kidney transplant patient with Coronavirus Disease 2019 (COVID-19).
000092 (2020) Kenneth Maiese [États-Unis]The mechanistic target of rapamycin (mTOR): Novel Considerations as an Antiviral Treatment and Possibilities for COVID-19.
000129 (2020) Sijia Li [République populaire de Chine] ; Yilin Wang [République populaire de Chine] ; Jia Xue ; Nan Zhao ; Tingshao ZhuThe Impact of COVID-19 Epidemic Declaration on Psychological Consequences: A Study on Active Weibo Users
000188 (2020) Tabitha A. Cheng [États-Unis] ; Bandr Mzahim [Arabie saoudite] ; Kristi L. Koenig [États-Unis] ; Abdulrahman Alsugair [Arabie saoudite] ; Abdussalam Al-Wabel [Arabie saoudite] ; Bandar Saad Almutairi [Arabie saoudite] ; Eshmawi Maysa [Arabie saoudite] ; Christopher A. Kahn [États-Unis]Scabies: Application of the Novel Identify-Isolate-Inform Tool for Detection and Management
000191 (2020) Cheng-I. Wu [Pays-Bas] ; Pieter G. Postema [Pays-Bas] ; Elena Arbelo ; Elijah R. Behr [Royaume-Uni] ; Connie R. Bezzina [Pays-Bas] ; Carlo Napolitano [Italie] ; Tomas Robyns [Belgique] ; Vincent Probst [France] ; Eric Schulze-Bahr [Allemagne] ; Carol Ann Remme [Pays-Bas] ; Arthur A. M. Wilde [Pays-Bas]SARS-CoV-2, COVID-19 and inherited arrhythmia syndromes
000272 (2020) Andrea T. Obi ; Geoff D. Barnes ; Thomas W. Wakefield ; Sandra Brown Rvt ; Jonathon L. Eliason ; Erika Arndt ; Peter K. HenkePractical diagnosis and treatment of suspected venous thromboembolism during COVID-19 Pandemic
000286 (2020) David Jiménez-Pav N [Espagne] ; Ana Carbonell-Baeza [Espagne] ; Carl J. Lavie [États-Unis]Physical exercise as therapy to fight against the mental and physical consequences of COVID-19 quarantine: Special focus in older people☆
000314 (2020) Samad Ghaffari [Iran] ; Neda Roshanravan [Iran] ; Helda Tutunchi [Iran] ; Alireza Ostadrahimi [Iran] ; Mahboub Pouraghaei [Iran] ; Behnam Kafil [Iran]Oleoylethanolamide, A Bioactive Lipid Amide, as A Promising Treatment Strategy for Coronavirus/COVID-19
000316 (2020) Sarah Robinson [États-Unis] ; Christine B. Peterson [États-Unis] ; Pranoti Sahasrabhojane [États-Unis] ; Nadim J. Ajami [États-Unis] ; Samuel A. Shelburne [États-Unis] ; Dimitrios P. Kontoyiannis [États-Unis] ; Jessica R. Galloway-Pe A [États-Unis]Observational Cohort Study of Oral Mycobiome and Interkingdom Interactions over the Course of Induction Therapy for Leukemia
000410 (2020) Anna Rogala [Pologne] ; Maria Szczepaniak [Pologne] ; Natalia Michalak [Pologne] ; Gerhard Andersson [Suède]Internet-based self-help intervention aimed at increasing social self-efficacy among internal migrants in Poland: Study protocol for a randomized controlled trial
000429 (2020) Ruklanthi De Alwis [Singapour] ; Shiwei Chen [Singapour] ; Esther S. Gan [Singapour] ; Eng Eong Ooi [Singapour]Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development
000473 (2020) Rozhgar A. Khailany [Iraq] ; Muhamad Safdar [Pakistan] ; Mehmet Ozaslan [Turquie]Genomic characterization of a novel SARS-CoV-2
000478 (2020) Marie Von Lilienfeld-Toal [Allemagne] ; Jörg Janne Vehreschild [Allemagne] ; Oliver Cornely [Allemagne] ; Livio Pagano [Italie] ; Francesca Compagno [Italie] ; Hans H. Hirsch [Suisse]Frequently asked questions regarding SARS-CoV-2 in cancer patients-recommendations for clinicians caring for patients with malignant diseases.
000510 (2020) Amr H. Sawalha [États-Unis] ; Ming Zhao [République populaire de Chine] ; Patrick Coit [États-Unis] ; Qianjin Lu [République populaire de Chine]Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients
000523 (2020) Richard I. Horowitz [États-Unis] ; Phyllis R. Freeman [États-Unis] ; James Bruzzese [États-Unis]Efficacy of glutathione therapy in relieving dyspnea associated with COVID-19 pneumonia: A report of 2 cases
000557 (2020) Jian-Sheng KangDietary restriction of amino acids for Cancer therapy

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "therapy" 
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "therapy" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    StressCovidV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    therapy
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed May 6 16:44:09 2020. Site generation: Sun Mar 28 08:26:57 2021